- Bortezomib, sold
under the
brand name
Velcade among others, is an anti-cancer
medication used to
treat multiple myeloma and
mantle cell lymphoma. This...
- research. It is
particularly known for
bringing bortezomib (marketed as
Velcade)
through clinical trials to
approval for
treatment of
patients with multiple...
-
Darzalex Eprex Erleada Imbruvica Procrit Rybrevant Talvey Tecvayli Valchlor Velcade Yondelis Zytiga Cardiovascular, metabolism, and
retina therapies Xarelto...
- present".
Green tea
interferes with the
chemotherapy drug
bortezomib (
Velcade) and
other boronic acid-based
proteasome inhibitors, and
should be avoided...
-
clinical trials across a
range of
disease areas, and is the co-developer of
Velcade, a drug used to
treat multiple myeloma.
Elliott was born in Cardiff, Wales...
- in
cancer drug research, for US$8.8 billion. The
acquisition brought in
Velcade, a drug
indicated for
hematological malignancies, as well as a portfolio...
-
initiated the
development by the
company of
proteasome inhibitor Bortezomib/
Velcade,
which is used
worldwide to
treat the
common hematological cancer, multiple...
-
brandnames and lower-case
letters for
generic drug names, e.g., VRd for
Velcade (brandname for bortezomib),
Revlimid (brandname for lenalidomide) and dexamethasone...
-
Bosutinib (Bosulif)
Ponatinib (Iclusig)
Asciminib (Scemblix)
Bortezomib (
Velcade) is an apoptosis-inducing
proteasome inhibitor drug that
causes cancer...
-
including most
commonly with
thalidomide (Thal-dex), lenalidomide,
bortezomib (
Velcade, Vel-dex), or a
combination of
doxorubicin (Adriamycin) and vincristine...
